TrialInternational journal of chronic obstructive pulmonary disease2014

Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect.

Thomas M Siler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.